Investors Research Corp’s Elevance Health ELV Stock Holding History
Bought
Maintained
Sold
Other funds holding ELV
RT
PAS
MSV
AMBIA
BRCM
FFA
BFA
TFA
CI
HAG
Investors Research Corp's ELV Position: Q3 2026 in Review
Investors Research Corp held its Elevance Health (ELV) position steady in Q3 2026 at 282 shares worth $110K. The position accounts for 0.02% of the portfolio, ranked #317.
Investors Research Corp first reported a position in ELV in Q4 2017 and has held it in 32 quarters since. The position peaked at $203K in Q4 2017. 64 funds tracked by Wall St. Rank hold ELV as of Q3 2026.
- Investors Research Corp held 282 shares of Elevance Health worth $110K as of Q3 2026.
- Investors Research Corp left its Elevance Health share count unchanged in Q3 2026.
- Elevance Health made up 0.02% of Investors Research Corp's portfolio in Q3 2026, its #317 holding.
- Investors Research Corp first reported a position in Elevance Health in Q4 2017 and has held it in 32 quarters since.
- Investors Research Corp's Elevance Health position peaked at $203K in Q4 2017.
- 64 funds tracked by Wall St. Rank held Elevance Health as of Q3 2026.
Based on Investors Research Corp's 13F filing for Q3 2026, filed 7 Oct 2026.